Curanex Pharmaceuticals Inc (CURX)
NASDAQ: CURXHealthcareBiotechnologyUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
CURX stock chart
Technical analysisKey statistics
All statistics- Market cap
- $7.46M
- EPS (TTM)
- -$7.80
- Dividend yield
- None
- 52-week range
- 3.58 – 16.94
- Day range
- 4.51 – 4.88
- Volume / Avg
- 14.38K / 19.65K
- Beta
- —
- Shares outstanding
- 1.57M
52-week range
CURX stock today
On Oct 8, CURX ended the session at $4.76, shedding $0.045 (0.94%), versus the S&P 500's 0.47% decline. At this level, CURX sits near the bottom of its 52-week range of $3.58 to $16.94: 71.9% below the high and 33.0% above the low. Curanex Pharmaceuticals has posted a net loss over the last twelve months (EPS of -$7.80), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Curanex Pharmaceuticals
Company profileCuranex Pharmaceuticals Inc, a developmental stage pharmaceutical company, discovers, develops, and commercializes botanical drugs to treat patients with inflammatory diseases. It develops Phyto-N for various therapeutic areas, including ulcerative colitis, atopic dermatitis, COVID-19, diabetes, nonalcoholic fatty liver disease, and gout. The company was formerly known as Fordman Pharma Inc.
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Jun Liu
- Headquarters
- Jericho, NY
- Employees
- 6
- IPO year
- 2025
- Website
- curanexpharma.com
Curanex Pharmaceuticals peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CLGNCollPlant Biotechnologies Ltd | 3.97 | +14.74% | $7.51M | vs CURX |
| SKYESkye Bioscience Inc. | 1.68 | +1.82% | $7.44M | vs CURX |
| SNGXSoligenix Inc. | 0.3466 | -1.95% | $7.54M | vs CURX |
| LGVNLongeveron Inc. Class A | 2.37 | -2.87% | $7.56M | vs CURX |
| TRAWTraws Pharma Inc. | 0.4803 | +0.27% | $7.38M | vs CURX |
| FBLGFibroBiologics Inc. | 1.11 | -2.63% | $7.72M | vs CURX |
| AIMAIM ImmunoTech Inc. | 0.1796 | -1.75% | $7.17M | vs CURX |
| CNSPCNS Pharmaceuticals Inc. | 5.35 | -1.47% | $7.82M | vs CURX |
Indexes, lists and sector
Appears in lists
Curanex Pharmaceuticals stock FAQ
What is Curanex Pharmaceuticals's stock price today?
CURX last traded at $4.76 as of Oct 8, 4:00 PM EDT, down 0.94% on the day. Prices are delayed at least 15 minutes.
Who is Curanex Pharmaceuticals's CEO?
Mr. Jun Liu is the chief executive officer of Curanex Pharmaceuticals Inc, which has about 6 employees.
What is the CURX 52-week high?
The 52-week high for CURX is $16.94 and the 52-week low is $3.58. The stock is currently 71.9% below its high.